Literature DB >> 11942696

Structural characteristics of ionotropic glutamate receptors as identified by channel blockade.

L G Magazanik1, K V Bol'shakov, S L Buldakova, V E Gmiro, N A Dorofeeva, N Ya Lukomskaya, N N Potap'eva, M V Samoilova, D B Tikhonov, I M Fedorova, E V Frolova.   

Abstract

The channels of four types of ionotropic glutamate receptor (NMDA receptors and Ca-permeable AMPA receptors of rat brain neurons, and cation-selective receptors from mollusk neurons and insect postsynaptic muscle membranes) and two subtypes of nicotinic cholinoreceptor (from frog neuromuscular junctions and cat sympathetic ganglia) were studied. The structural characteristics of channels determining their susceptibility to blockade by organic mono- and dications were identified. These studies used homologous series of adamantane and phenylcyclohexyl derivatives. These experiments showed that the receptors studied here could be divided into two groups. The first group included the AMPA receptor and the mollusk and insect receptors. These were characterized by the lack of effect on the part of monocations and a strong relationship between the activity of dications and the distance between nitrogen atoms. The second group included the NMDA receptor and both subtypes of the nicotinic cholinoreceptor (muscular and neuronal). Here, conversely, the activity of monocations and dications, regardless of their lengths, were essentially identical. A model for the binding sites of blockers in channels is proposed, which takes these observations into account.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11942696     DOI: 10.1023/a:1013979525872

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  40 in total

Review 1.  The glutamate receptor ion channels.

Authors:  R Dingledine; K Borges; D Bowie; S F Traynelis
Journal:  Pharmacol Rev       Date:  1999-03       Impact factor: 25.468

2.  Stoichiometry of recombinant N-methyl-D-aspartate receptor channels inferred from single-channel current patterns.

Authors:  L S Premkumar; A Auerbach
Journal:  J Gen Physiol       Date:  1997-11       Impact factor: 4.086

3.  Synaptic distribution of the AMPA-GluR2 subunit and its colocalization with calcium-binding proteins in rat cerebral cortex: an immunohistochemical study using a GluR2-specific monoclonal antibody.

Authors:  P Vissavajjhala; W G Janssen; Y Hu; A H Gazzaley; T Moran; P R Hof; J H Morrison
Journal:  Exp Neurol       Date:  1996-12       Impact factor: 5.330

4.  The tetrameric structure of a glutamate receptor channel.

Authors:  C Rosenmund; Y Stern-Bach; C F Stevens
Journal:  Science       Date:  1998-06-05       Impact factor: 47.728

Review 5.  Allosteric receptors after 30 years.

Authors:  J P Changeux; S J Edelstein
Journal:  Neuron       Date:  1998-11       Impact factor: 17.173

6.  A simple perfusion system for patch-clamp studies.

Authors:  V S Vorobjev; I N Sharonova; H L Haas
Journal:  J Neurosci Methods       Date:  1996-10       Impact factor: 2.390

7.  Glutamate receptor subunit 2-selective antibody shows a differential distribution of calcium-impermeable AMPA receptors among populations of neurons.

Authors:  R S Petralia; Y X Wang; E Mayat; R J Wenthold
Journal:  J Comp Neurol       Date:  1997-09-01       Impact factor: 3.215

8.  Molecular cloning of an invertebrate glutamate receptor subunit expressed in Drosophila muscle.

Authors:  C M Schuster; A Ultsch; P Schloss; J A Cox; B Schmitt; H Betz
Journal:  Science       Date:  1991-10-04       Impact factor: 47.728

9.  Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS.

Authors:  J R Geiger; T Melcher; D S Koh; B Sakmann; P H Seeburg; P Jonas; H Monyer
Journal:  Neuron       Date:  1995-07       Impact factor: 17.173

10.  Novel adamantane derivatives act as blockers of open ligand-gated channels and as anticonvulsants.

Authors:  S M Antonov; J W Johnson; N Y Lukomskaya; N N Potapyeva; V E Gmiro; L G Magazanik
Journal:  Mol Pharmacol       Date:  1995-03       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.